Evotec AG Reports Results of the First Nine Months of 2015
10 nov. 2015 02h46 HE
|
Evotec AG
Strong Growth in Revenues and ProfitsThree Major EVT Innovate Deals ConcludedRevenue Guidance Raised on 15 September 2015 HAMBURG, Germany, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Evotec AG...
Evotec AG Increases Its Revenue Guidance for 2015
15 sept. 2015 01h40 HE
|
Evotec AG
HAMBURG, Germany, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it increases its financial guidance for the current...
Evotec to Present at Two Upcoming IR Conferences
10 sept. 2015 09h33 HE
|
Evotec AG
HAMBURG, Germany, Sept. 10, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX, ISIN: DE0005664809) announced today that its CEO, Dr Werner Lanthaler, will present at the Morgan Stanley...
Evotec Enters Into Licence and Collaboration Agreement With Pfizer Inc. in Tissue Fibrosis
09 sept. 2015 01h38 HE
|
Evotec AG
HAMBURG, Germany, Sept. 09, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has signed an agreement on a four-year research collaboration with...
Evotec and CHDI Foundation Expand Ongoing Collaboration to Fight Huntington’s Disease Using Evotec’s Expanded Capabilities and Footprint
02 sept. 2015 01h40 HE
|
Evotec AG
HAMBURG, Germany, Sept. 02, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced that CHDI Foundation, Inc. (“CHDI”) has extended and...
Evotec AG Reports Results of First Half of 2015
12 août 2015 02h06 HE
|
Evotec AG
STRONG PERFORMANCE OF EVT EXECUTE SERVICES ACCELERATION OF EVT INNOVATE STRATEGY HAMBURG, Germany, Aug. 12, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX)...
Evotec, Apeiron Biologics and Sanofi Jointly Develop Novel Small Molecule-Based Cancer Immunotherapies
10 août 2015 01h27 HE
|
Evotec AG
HAMBURG, Germany, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) and Apeiron Biologics AG, a biotech company with a focus on immunological...
Sanofi and Evotec Align Forces to Develop Next Generation Therapies in Diabetes
07 août 2015 01h14 HE
|
Evotec AG
Development of beta cell replacement therapyDiscovery and development of beta cell modulating drugsRisk-shared transaction exceeding € 300 m milestone potential and significant royalties for...
Evotec to Report First Half-Year 2015 Results on 12 August 2015
05 août 2015 06h12 HE
|
Evotec AG
HAMBURG, Germany, Aug. 05, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first half of 2015 on Wednesday, 12 August 2015. ...
Evotec Enters Innovative Research Initiative With Gladstone Institutes and Dolby Family Ventures in Alzheimer’s Disease
24 juil. 2015 01h46 HE
|
Evotec AG
SAN FRANCISCO and HAMBURG, Germany, July 24, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has become part of a research...